218 related articles for article (PubMed ID: 25818107)
1. Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.
Grødeland G; Bogen B
Expert Rev Vaccines; 2015 Jun; 14(6):805-14. PubMed ID: 25818107
[TBL] [Abstract][Full Text] [Related]
2. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.
Andersen TK; Zhou F; Cox R; Bogen B; Grødeland G
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931687
[TBL] [Abstract][Full Text] [Related]
3. Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza.
Mooij P; Grødeland G; Koopman G; Andersen TK; Mortier D; Nieuwenhuis IG; Verschoor EJ; Fagrouch Z; Bogers WM; Bogen B
Vaccine; 2019 Feb; 37(6):817-826. PubMed ID: 30638800
[TBL] [Abstract][Full Text] [Related]
4. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
[TBL] [Abstract][Full Text] [Related]
5. Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief.
Andersen TK; Bodin J; Oftung F; Bogen B; Mjaaland S; Grødeland G
Front Immunol; 2021; 12():747032. PubMed ID: 34691056
[TBL] [Abstract][Full Text] [Related]
6. Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice.
Fang J; Chen Z; Liu X; Li H; Wang J; Shen X; Chen W; Liu Y; Wang Y; Zhao P; Qi Z
J Virol Methods; 2011 May; 173(2):314-9. PubMed ID: 21392537
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice.
Chen J; Liu Q; Chen Q; Xiong C; Yao Y; Wang H; Wang H; Chen Z
Arch Virol; 2014 Apr; 159(4):689-700. PubMed ID: 24132721
[TBL] [Abstract][Full Text] [Related]
8. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
Smith LR; Wloch MK; Ye M; Reyes LR; Boutsaboualoy S; Dunne CE; Chaplin JA; Rusalov D; Rolland AP; Fisher CL; Al-Ibrahim MS; Kabongo ML; Steigbigel R; Belshe RB; Kitt ER; Chu AH; Moss RB
Vaccine; 2010 Mar; 28(13):2565-72. PubMed ID: 20117262
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of seasonal pandemic influenza hemagglutinin DNA vaccines delivered by electroporation against a seasonal H1N1 virus challenge in mice.
Tan L; Lu H; Zhang D; Wang K; Tian M; Liu C; Liu Y; Hu B; Jin N
Sci China Life Sci; 2011 Apr; 54(4):293-9. PubMed ID: 21416231
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza.
Werninghaus IC; Hinke DM; Fossum E; Bogen B; Braathen R
Mol Ther; 2023 Jul; 31(7):2188-2205. PubMed ID: 36926694
[TBL] [Abstract][Full Text] [Related]
11. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
[TBL] [Abstract][Full Text] [Related]
12. Learning from the 2009 H1N1 pandemic: prospects for more broadly effective influenza vaccines.
Settembre EC; Dormitzer PR; Rappuoli R
J Mol Cell Biol; 2011 Jun; 3(3):144-6. PubMed ID: 21430014
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
[TBL] [Abstract][Full Text] [Related]
14. A one-size-fits-all flu vaccine?
Kaiser J
Science; 2006 Apr; 312(5772):380-2. PubMed ID: 16627732
[No Abstract] [Full Text] [Related]
15. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
[TBL] [Abstract][Full Text] [Related]
16. The highly conserved HA2 protein of the influenza A virus induces a cross protective immune response.
Lee JS; Chowdhury MY; Moon HJ; Choi YK; Talactac MR; Kim JH; Park ME; Son HY; Shin KS; Kim CJ
J Virol Methods; 2013 Dec; 194(1-2):280-8. PubMed ID: 24004822
[TBL] [Abstract][Full Text] [Related]
17. Protection abilities of influenza B virus DNA vaccines expressing hemagglutinin, neuraminidase, or both in mice.
Fang F; Cai XQ; Chang HY; Wang HD; Yang ZD; Chen Z
Acta Virol; 2008; 52(2):107-12. PubMed ID: 18564897
[TBL] [Abstract][Full Text] [Related]
18. Improved immune responses against avian influenza virus following oral vaccination of chickens with HA DNA vaccine using attenuated Salmonella typhimurium as carrier.
Jazayeri SD; Ideris A; Zakaria Z; Yeap SK; Omar AR
Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):417-27. PubMed ID: 22512819
[TBL] [Abstract][Full Text] [Related]
19. H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?
Rudenko L; Isakova-Sivak I; Rekstin A
Expert Rev Vaccines; 2014 Jan; 13(1):1-4. PubMed ID: 24308582
[TBL] [Abstract][Full Text] [Related]
20. Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein.
Pertmer TM; Robinson HL
Virology; 1999 May; 257(2):406-14. PubMed ID: 10329551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]